SCHEMBL8989246

SCHEMBL8989246

Cc1ccc(-c2nc(C)c(CO)o2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 2/20 0.49
NPC1 O15118 8/20 0.45
RAB9A P51151 8/20 0.45
SMN1; SMN2 Q16637 6/20 0.45
KDM4E B2RXH2 6/20 0.45
ALDH1A1 P00352 6/20 0.45
HSD17B10 Q99714 5/20 0.45
HPGD P15428 5/20 0.45
TP53 P04637 3/20 0.45
TARBP2 Q15633 1/20 0.44
NFKB1 P19838 3/20 0.44
NFKB2 Q00653 3/20 0.44
RELA Q04206 3/20 0.44
MAPT P10636 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
POLB P06746 1/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
PPARD Q03181 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9831245 0.86 KDM4E (0.52) IKBKBNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL9831294 0.86 NPC1 (0.44) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL821117 0.86 IKBKB (0.46) IKBKBNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL6377222 0.86 KDM4E (0.51) IKBKBNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL13361730 0.84 IKBKB (0.46) IKBKBNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL5639362 0.83 TARBP2 (0.54) IKBKBNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL9830290 0.83 KDM4E (0.41) IKBKBRAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL4467452 0.82 PPARD (0.58) IKBKBNPC1KDM4EALDH1A1HSD17B10
SCHEMBL8989102 0.82 IKBKB (0.45) IKBKBNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL13455121 0.82 IKBKB (0.45) IKBKBNPC1RAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 US disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 US disclosed